AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
295.03
+0.58 (0.20%)
At close: Nov 13, 2026, 4:00 PM EST
297.98
+2.95 (1.00%)
Pre-market: Nov 16, 2026, 5:59 AM EST
AbbVie Employees
AbbVie had 57,000 employees as of December 31, 2025. The number of employees increased by 2,000 or 3.64% compared to the previous year. That makes AbbVie the 629th largest employer in the world and 174th in the United States.
Employees
57,000
Change (1Y)
2,000
Growth (1Y)
3.64%
Revenue / Employee
$1,158,140
Profits / Employee
$180,754
Market Cap
521.50B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57,000 | 2,000 | 3.64% |
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | 0 | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 66,700 |
| Eli Lilly and Company | 50,000 |
ABBV News
- 52 minutes ago - AbbVie price target raised to $335 from $325 at Barclays - TheFly
- 7 days ago - AbbVie’s Allergan Aesthetics announces results from Harmony In Diversity, Halo - TheFly
- 7 days ago - Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications - PRNewsWire
- 9 days ago - Healthcare Stocks Fall as Market Rout Spreads - WSJ
- 11 days ago - AbbVie price target raised to $315 from $285 at Freedom Broker - TheFly
- 12 days ago - AbbVie expands Oxford R&D facility as part of £120 million-plus investment - Reuters
- 12 days ago - Allergan Aesthetics to Present New Research on Aesthetic Care Following Medical Weight Loss and Evolving Patient Needs at ASDS 2026 - PRNewsWire
- 13 days ago - AbbVie price target raised to $330 from $280 at RBC Capital - TheFly